Calculus Q2 2023 Update
Calculus Q2 2023 Quarterly Update showcasing some great news stories from our portfolio companies.
Calculus Q2 2023 Quarterly Update showcasing some great news stories from our portfolio companies.
Arctic Shores are to work with some of the largest brewing brands on a new recruitment drive.
Its new documentary explores the legacy of famed music art studio Hipgnosis.
The new trial is designed to build on preliminary data supporting the notion that OBT-076 is able to deliver immune priming in chemo-refractory, advanced cancer patients.
The collaboration will see a new Phase 1b trial undertaken, investigating OBT’s lead asset, OBT076, in patients with Adenoid Cystic Carcinoma (ACC), a rare and aggressive type of cancer
The grant from the Medical Technology Enterprise Consortium (MTEC) will support the continued development of its fully portable handheld DeepView device
CEO, John Glencross quoted in this article regarding the potential removal of the sunset clause.
Modi-1 cancer vaccine showed partial response and stable disease in patients with hard-to-treat head and neck, high grade serous ovarian or triple negative breast cancers.
John Glencross, Chief Executive of Calculus, is quoted in City AM, speaking about how EIS can mitigate inheritance tax.
Kristen Stewart is to play US writer, philosopher and political activist Susan Sontag in an upcoming feature for Brouhaha